Collaborating on Establishing "Blockchain + Stablecoin + Smart Cold Chain" Smart Agricultural EcosystemHONG KONG, June 26, 2025 (GLOBE NEWSWIRE) -- Reitar Logtech Holdings Limited (NASDAQ: RITR) (“Reitar” or the “Company”), a pioneer in providing comprehensive "Property Logistics Technology (PLT)" solutions, today announced the signing of a strategic Memorandum of Understanding (the “MOU”) with Rich Harvest Agricultural Produce Limited (“Rich Harvest”), a leading Asian smart agriculture enterprise. With eig ...

FORT WORTH, Texas, June 26, 2025 (GLOBE NEWSWIRE) -- Lottery.com Inc. (NASDAQ: LTRY, LTRYW) (“Lottery.com” or “the Company”), a leading technology company transforming the intersection of gaming, sports and entertainment, today announced it is advancing its global expansion with the planned launch of the Sports.com Super App (the “Super App”)—a first-of-its-kind digital destination for sports fans worldwide. The Super App is designed to combine live streaming, social engagement, e-commerce and gamification ...

Brings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansionLed successful organizational turnarounds and growth strategies at both Boston Heart Diagnostics and Genova DiagnosticsExtensive track record in commercializing advanced laboratory testing, driving growth and payer strategies IRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today ann ...

MONROE TOWNSHIP, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (OPT or the “Company”) (NYSE American: OPTT), a leader in innovative and sustainable marine energy and data solutions, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for its U.S. patent application titled “System and Method for Vehicle Charging.” The newly allowed patent (Application No. 18/936,528) protects OPT’s breakthrough system for an autonomous, floating ...

Partnership Provides Long-Term Supply of Iodine-125 and Actinium-225 Supports Advancement of Radiotherapeutic Pipeline and Plans to Initiate Phase 1b Clinical Trial of CLR-125 for Triple-Negative Breast Cancer FLORHAM PARK, N.J. and WEST VALLEY CITY, Utah, June 26, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, and Nusano, a physics company transforming the pro ...

Juve Stabia’s squad value has risen 245%, from $9.3M to $32.3M over the 2024-25 season, as the team climbed to 5th place in Italy’s Serie B final football standings Juve Stabia’s squad value has risen 245%, from $9.3M to $32.3M over the 2024-25 season, as the team climbed to 5th place in Italy’s Serie B final football standings Juve Stabia’s squad value has risen 245%, from $9.3M to $32.3M over the 2024-25 season, as the team climbed to 5th place in Italy’s Serie B final football standings Dublin, Irel ...

American Rebel Holdings Inc American Rebel Light Beer Online Orders Soar as American Rebel Beer Ships to Over 40 States; Free Shipping Available Through June 30 NASHVILLE, TN, June 26, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American Rebel" or the "Company"), creator of American Rebel Beer (americanrebelbeer.com) and a designer, manufacturer, and marketer of branded safes, personal security and self-defense products and apparel, proudly reports explosive online sales grow ...

JERUSALEM, June 26, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, announced that new data exploring the dual actions of EB613 on trabecular and cortical bone was selected for oral presentation at the American Society for Bone and Mineral Research (ASBMR) 2025 Annual Meeting, taking place September 5-8 in Seattle, Washington, USA. EB613 is being developed as the first once-daily oral anabolic (bone forming) PTH(1-34) ...

ASCEND comprises two dosing regimens of certepetide evaluated in two separate study arms enrolled sequentially Positive signal in progression-free survival and objective response rate observed in certepetide-treated group compared to placebo-treated group Cohort B data corroborate Cohort A data indicating certepetide has a treatment effect and an attractive safety profile Full study data from both cohorts expected later this year BARCELONA, Spain, June 26, 2025 (GLOBE NEWSWIRE) -- The Australasian Gastro-In ...

The American Academy of Dermatology (AAD) provided evidence-based recommendation for the use of ZORYVE® (roflumilast) cream 0.15% in adults with mild to moderate atopic dermatitis (AD)Recommendation reflects ZORYVE’s proven efficacy, safety, and tolerability as a next-generation, steroid-free, topical phosphodiesterase-4 (PDE4) inhibitorAmong newly evaluated branded topical therapies, ZORYVE is the only treatment with a strong recommendation for adults with mild to moderate atopic dermatitis in AAD’s focuse ...